Very very cool. Did she say what her next projects are?
One thing that stuck out to me and brought up a whole different issue was: "So, while the agency recognized that the pill had some impact, the FDA was looking for a drug that would take effect in a more instantly gratifiable manner. The advising agency will continue to test, looking for the endpoint desired by the FDA..." I am a little confused, then, about the FDA's role in approving a new drug. This makes it sound like the FDA is actually driving the drug-making process by saying what "endpoint it desires." Does this mean that the FDA is actually kind of calling out to drug-makers saying what drug they want made and what specifically they want it to do? (e.g. Be fast acting) I don't know much about the FDA's processes when it comes to this.
Comment Reply
Very very cool. Did she say what her next projects are?
One thing that stuck out to me and brought up a whole different issue was: "So, while the agency recognized that the pill had some impact, the FDA was looking for a drug that would take effect in a more instantly gratifiable manner. The advising agency will continue to test, looking for the endpoint desired by the FDA..." I am a little confused, then, about the FDA's role in approving a new drug. This makes it sound like the FDA is actually driving the drug-making process by saying what "endpoint it desires." Does this mean that the FDA is actually kind of calling out to drug-makers saying what drug they want made and what specifically they want it to do? (e.g. Be fast acting) I don't know much about the FDA's processes when it comes to this.
September 1, 2010 - 12:04pmThis Comment
Reply